Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04166565 |
| Title | Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease (EMN19) |
| Acronym | EMN19 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | European Myeloma Network |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | TUR | ITA | GRC |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Athens | Athens | Greece | Details | |||
| Anticancer Hospital of Thessaloniki | Thessaloníki | Greece | Details | |||
| University of Bologna | Bologna | Italy | Details | |||
| Univerity of Turin | Torino | Italy | Details | |||
| Ankara University | Ankara | Turkey | Details | |||
| Dokuz Eylul University | Balçova | Turkey | Details | |||
| Erciyes University | Kayseri | Turkey | Details | |||
| Marmara University | Pendik | Turkey | Details |